Panacea Journal of Medical Sciences

---

To study indication’s outcomes and complications of non-invasive ventilation in acute respiratory failure

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Sanchit Mohan*, Vishwanath Pujari, Priti Meshram

Volume : 13, Issue : 2, Year : 2023

Article Page : 309-315

https://10.18231/j.pjms.2023.060

Suggest article by email

---

Abstract

Background: Failure of respiratory system in one or both of its gas-exchanging functions- oxygenation of pulmonary arterial blood and carbon-dioxide elimination from mixed venous blood. Non-Invasive Ventilation is an alternative to invasive ventilation in many conditions it is a valuable component in patient management. Its use in acute respiratory failure is widely accepted and well known.
Aim: To Study the indications, outcomes, and complications of NIV.
Materials and Methods: This is a prospective observational study conducted on 100 patients admitted with either Type-I or Type -II respiratory failure.
Results: Various common indications for use of NIV in acute Respiratory Failure are COPD, ILD, Bronchiectasis, Pneumonia, Pulmonary Thromboembolism, Kyphoscoliosis, and Pulmonary Tuberculosis in that order. The overall success rate of NIV is 84%.
Conclusion: NIV helps in improving gas exchange in acute respiratory failure irrespective of its type, reduces intubation and length of hospital stay hence, its use as the first modality of treatment in patients without overt contraindications is recommended. Overall, NIV is safe and effective in patients with acute respiratory failure as there are no major complications associated with its use.
 

Keywords: Respiratory failure, Complications, Non­Invasive Ventilation

How to cite : Mohan S, Pujari V, Meshram P, To study indication’s outcomes and complications of non-invasive ventilation in acute respiratory failure. Panacea J Med Sci 2023;13(2):309-315

Copyright © 2023 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)